Ā | Ā | Basal | Post-exercise | ANOVA |
---|
NO LPS | LPS | NO LPS | LPS |
---|
IL1Ī² (pg/h 106 cells) | Placebo | 6.22āĀ±ā1.46 | 16.3āĀ±ā4.79$ | 6.68āĀ±ā1.51 | 21.1āĀ±ā7.34$ | A (.002) |
(Fā=ā10.673) |
Experimental | 9.35āĀ±ā2.24 | 17.6āĀ±ā6.28$ | 8.34āĀ±ā2.19 | 21.7āĀ±ā8.07$ | Fd (7,41) |
MCP1 (pg/h 106 cells) | Placebo | 32.1āĀ±ā9.79 | 36.1āĀ±ā4.07 | 36.2āĀ±ā6.14 | 45.4āĀ±ā3.87 | E(.002) |
(Fā=ā10.437) |
Experimental | 22.7āĀ±ā5.31 | 29.6āĀ±ā4.98 | 49.6āĀ±ā4.73# | 38.3āĀ±ā3.81 | Fd (7,41) |
- Statistical analysis: Two-way ANOVA, pā<ā0.05. S, Supplementation effect; A, LPS-stimulation effect, E, Exercise effect, SxA, interaction between Supplementation and LPS-stimulation effects, SxE, interaction between Supplementation and Exercise effects, ExA, interaction between Exercise and LPS activation effects, AxExS, interaction between effects of three factors. *Differences between Placebo and experimental groups; #difference between Basal and Post-exercise conditions p; $differences between NO LPS-stimulated and LPS-stimulated groups. When interaction exists between different groups, different letters reveal significant differences. Results are the meanāĀ±āSEM. Fd means Freedom degree